ChristianaCare Gene Editing Institute

The Gene Editing Institute advances the power of CRISPR gene editing technology to improve human life through groundbreaking research and development and by inspiring and helping to prepare the next generation of gene scientists. Launched at ChristianaCare in 2015 under the leadership of gene editing pioneer Eric Kmiec, Ph.D., the Gene Editing Institute is a world leader in CRISPR gene editing technology. It is the only institute of its kind embedded in a community health system and brings a unique patient focus to the cutting-edge science of CRISPR gene editing. As a wholly owned subsidiary of ChristianaCare, the Institute is positioned to fast-track new research discoveries to market. The Gene Editing Institute is divided into three teams of dedicated scientists and innovators. The Discovery Research Group explores the molecular basis of gene editing, providing leading expertise in a collaborative and novel research community and creating new tools and strategies for genome edit...